Brief ReportMyeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results
Under a Creative Commons license
open access
Graphical Abstract
Key Words
Heart failure
preserved ejection fraction
mildly reduced ejection fraction
myeloperoxidase
inflammation
pharmacokinetics
pharmacodynamics
randomized controlled trial
Cited by (0)
- †
Affiliation at the time the work was conducted: Research and Early Clinical Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
© 2023 The Authors. Published by Elsevier Inc.